"Completing the infrastructure workstream is a major de-risking milestone for Orom-Cross. Having hydro-grid power, water, ...

Worldpanel, formerly known as Kantar, noted that sales of branded grocery items increased 6.1% in August, ahead of grocers' own-label alternatives, which rose 4.1%. This was the largest gap in favour ...

Alien Metals said its joint venture partner, West Coast Silver Ltd, has reported further "outstanding" assay results from the maiden diamond drilling programme at the Elizabeth Hill project. West ...

The company hired white-label ETF provider Hanetf to support fund manager Middlefield. As of Friday, Hanetf has approval from the Central Bank of Ireland to set up the fund, and has applied to the UK ...

(Sharecast News) - London stocks had pared losses to trade flat by midday on Friday after closing at a fresh record a day earlier for the third session in a row, as investors eyed a speech by Federal ...

Chair Iain McDonald commented: "Revolution Beauty is a great brand, but the business has lost its way. We are confident that with a return to the founder-led management team who originally scaled the ...

(Sharecast News) - London stocks edged lower in early trade on Friday after closing at a fresh record a day earlier for the third session in a row, as investors eyed an upcoming speech by Federal ...

The natural gas and light oil assets company with operations in Mississippi said petroleum and natural gas sales rose 2.6% to USD4.0 million in the second quarter of 2025, from USD3.9 million a year ...

Ithaca declared a 10.1 US cents first interim dividend per share, representing a return to shareholders of USD167 million. The company confirmed its 2025 dividend target of USD500 million. It said it ...

Despite the fading rate cut hopes, the pound eased to USD1.3468 late on Wednesday afternoon in London, compared to USD1.3503 at the equities close on Tuesday. The euro edged down to USD1.1661, lower ...

(Alliance News) - Renishaw PLC on Thursday said its finance director will depart at the end of 2025 after 46 years at the firm, as it forecast annual adjusted pretax profit to be towards the top of ...

Helping its loss narrow was a 77% advance in revenue to USD21.4 million from USD12.1 million, with Shield Therapeutics benefitting from increased US sales of Accrufer. Sales in the region climbed 75% ...